Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy

J Am Acad Dermatol. 2015 Oct;73(4):705-6. doi: 10.1016/j.jaad.2015.06.063.

Authors

Shannon Famenini¹, Christa Slaught¹, Lewei Duan², Carolyn Goh³

Affiliations

¹ David Geffen School of Medicine at the University of California, Los Angeles, California.
² UCLA David Geffen School of Medicine, Department of Medicine, Statistical Core, Los Angeles, California.
³ Department of Medicine, Division of Dermatology, UCLA Medical Center, Los Angeles, California. Electronic address: [email protected].

No abstract available

Publication types

Evaluation Study
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Alopecia / diagnosis
Alopecia / drug therapy*
Alopecia / epidemiology*
Cohort Studies
Demography
Female
Follow-Up Studies
Humans
Incidence
Middle Aged
Retrospective Studies
Risk Assessment
Severity of Illness Index
Spironolactone / therapeutic use*
Statistics, Nonparametric
Treatment Outcome

Substances

Spironolactone

Grants and funding